News
16h
Clinical Trials Arena on MSNSellas doses first paediatric subject with AML in Phase II trial of SLS009Sellas Life Sciences has dosed the first paediatric subject with acute myeloid leukaemia (AML) in its multi-centre Phase II ...
The FDA also approved the use of Zynyz as a monotherapy for patients with squamous cell carcinoma of the anal canal who are ...
1d
Clinical Trials Arena on MSNPasithea to commence Phase I/Ib trial of neurofibromatosis type 1 therapyPasithea Therapeutics has announced the start of a Phase I/Ib open-label trial of macrocyclic mitogen-activated protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results